Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Autologous Umbilical Cord Blood----[2] 211, 294
2Bronchodilator Response----[1] 294
3Diagnostic Test: Fecal microbiome probiotic----[1] 294
4Diagnostic Test: Functional residual capacity----[1] 294
5Diagnostic Test: initial fecal microbiome----[1] 294
6Diagnostic Test: initial pulmonary microbiome----[1] 294
7Diagnostic Test: initial VOC----[1] 294
8Diagnostic Test: Maximum oxygen uptake[1] Oxygen[1] D00003 --[1] 294
9Diagnostic Test: Pulmonary microbiome probiotic----[1] 294
10Diagnostic Test: VOC probiotic----[1] 294
11Gold[1] Gold---[43] 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 171, 193, 218, 222, 224, 227, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318
12Hypersaline----[1] 294
13INALOSSIN - 800 PPM MOL/MOL GAS MEDICINALE COMPRESSO BOMBOLA IN ALLUMINIO CON VALVOLA VI DA 20 LITRI----[1] 294
14INALOSSIN 800 PPM MOL/MOL GAS MEDICINALE COMPRESSO----[1] 294
15Inhaled Nitric Oxide (iNO) use[1] Nitric Oxide[1] D00074 --[1] 294
16INOmax[1] Nitric Oxide[1] D00074 --[3] 85, 294, 299
17INOmax 800ppm mol/mol inhalatiegas[1] Nitric Oxide[1] D00074 --[1] 294
18Losec[1] Omeprazole[4] D00455 ,
D01207 ,
D05259 ,
D05261 		[2] ATP4A,
ATP4B 💬		[4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬[3] 46, 225, 294
19Milrinone[1] Milrinone[2] D00417 ,
D02085 		[2] PDE3A,
PDE3B 💬		[11] Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 294
20Neophyr 1000ppm mol/mol----[1] 294
21Nitric Oxide[1] Nitric Oxide[1] D00074 --[8] 46, 85, 86, 98, 210, 251, 294, 299
22Omeprazol[1] Omeprazole[4] D00455 ,
D01207 ,
D05259 ,
D05261 		[2] ATP4A,
ATP4B 💬		[4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬[1] 294
23Omeprazole[1] Omeprazole[4] D00455 ,
D01207 ,
D05259 ,
D05261 		[2] ATP4A,
ATP4B 💬		[4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬[16] 6, 8, 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299
24Omeprazole rectally 1mg/kg[1] Omeprazole[4] D00455 ,
D01207 ,
D05259 ,
D05261 		[2] ATP4A,
ATP4B 💬		[4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬[1] 294
25OSSIDO DI AZOTO----[1] 294
26Other: De-implementation of Inhaled Nitric Oxide (iNO) use[1] Nitric Oxide[1] D00074 --[1] 294
27Oxygen[1] Oxygen[1] D00003 --[20] 6, 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 168, 193, 226, 271, 294, 299, 330
28Probiotic treatment----[1] 294
29Repair of CDH w/Alloderm----[1] 294
30Repair of CDH w/SIS Gold[1] Gold---[1] 294
31REVATIO - 0.8 MG/ML - SOLUZIONE INIETTABILE - USO ENDOVENOSO - FLACONCINO(VETRO) 1 FLACONCINO DA 20 ML[1] Sildenafil[2] D02229 ,
D08514 		[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 294
32Revatio 0.8mg/ml solution for injection----[1] 294
33Sildenafil[1] Sildenafil[2] D02229 ,
D08514 		[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[17] 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301